Association of Gestational Age in a Full Range With Childhood Overweight and Obesity: A Systematic Scoping Review

Yuantao Su1, Marini Ahmad Suhaimi2, Manish Prasad Gupta1

  • 1Department of Women's and Children's Health Care, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

Insights

Preterm birth is linked to childhood obesity, but evidence for term and post-term births is unclear. More research is needed on gestational age and childhood overweight risks.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Inconsistent associations exist between preterm birth and childhood obesity.
  • The impact of full gestational age on childhood overweight and obesity risk is not well understood.

Purpose of the Study:

  • To systematically review the relationship between gestational age at birth and childhood overweight/obesity.
  • To explore the entire spectrum of gestational age in relation to childhood obesity.

Main Methods:

  • Systematic scoping review of PubMed, Ovid Medline, and Google Scholar (2000-2024).
  • Included studies investigating childhood overweight/obesity outcomes in relation to gestational age.
  • Followed PRISMA-ScR guidelines for study selection.

Main Results:

  • Twenty-eight studies met inclusion criteria.
  • Preterm birth showed a substantial link to childhood overweight and obesity.
  • Evidence for term and post-term births was limited and showed mixed results.

Conclusions:

  • Limited evidence exists for the association between various gestational ages and childhood overweight/obesity.
  • Highlights the need for primary prevention strategies in early childhood.
  • Further research is required to clarify the nuanced relationship between gestational age and childhood obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...